Accueil   Calls for projects   EuroNanoMed III Joint Transnational Call for Proposals (2021)

EuroNanoMed III Joint Transnational Call for Proposals (2021)

Key features of the call for projects

Type de l'appel : Collaboratif

Opening date: November 16th, 2020

Date de clôture : January 21th, 2021

Dimension : Europe


Type de financement : Subvention

Appel d'offre thématisé

Thématique(s) médicale(s) : Medical Technologies, Micro and nano technologies

Secteur(s) industriel(s) : Diagnostic in vitro, Médicaments et vaccin à usage humain ou animal

The French National Research Agency (ANR), in partnership with 18 countries is set to launch a 11th joint transnational call for proposals through the ERA-NET EuroNanoMed (ENM) on Nanomedicine.


The goal of this call for proposals is to both support translational research projects that combine innovative approaches in the field of Nanomedicine and to encourage and enable transnational collaboration between public and private research groups from academia, clinical/public health research or research teams from industrial enterprises (all sizes). The participation of Medical Doctors and SMEs will be strongly encouraged.


This call for proposals includes funding research organisations of 19 potential participating countries: Belgium, Bulgaria, Canada, Czech Republic, Egypt, Estonia, France, Greece, Israel, Italy, Latvia, Lithuania, Norway, Poland, Romania, Slovakia, Spain, Taiwan, and Turkey. Project proposals will need to cover at least one of the following areas that are equal in relevance for this call:

  • Regenerative medicine
  • Diagnostic
  • Targeted delivery systems


At the end, the projects should fall within, but are not limited to, Technology Readiness Levels (TRL) 3-6, although for being realistic and coherent with the characteristics of the call, projects should propose advancements for a maximum of two TRL levels during their lifetime.

The proposals should clearly demonstrate a potential impact in the health and / or economic field as well as the added value of transnational collaboration.



Consortia composition

A consortium applying to this call will be required to include research group(s) from at least 2 of the 3 following categories:

  • Academia
  • Clinical/public health sector
  • Enterprise (all sizes of private companies)

Only transnational projects will be funded. Each consortium submitting a proposal will need to involve a minimum of 3 eligible and a maximum of 5 eligible partners from at least 3 different countries participating to the call. The project coordinator must be eligible to be funded by EuroNanoMed III participating countries/regions. No more than 2 eligible partners from the same country participating in the call will be accepted in one consortium.


Research groups not eligible to be funded (e.g. from non-funding countries or not fundable according to national/regional regulations of the participating funding countries) may participate in transnational projects if they are able to secure their own funding. However, no more than one research group with own funding will be included in a consortium and the coordinator will need to be eligible to be funded by the participating funding organisations.


The maximum number of partners will possibly be increased from 5 to 7 (including eligible for funding and non-eligible for funding research groups) if partners from these participating countries, whose scientific community has been under-represented in past EuroNanoMed calls, are included: Bulgaria, Czech Republic, Egypt, Estonia, Latvia, Lithuania, Romania, Slovakia, Taiwan, and Turkey.


Funding will be allocated for a maximum of three years. ANR will only fund french selected projects.

To find more information about this call